Niyati has more than 20 years’ experience in clinical settings and in the pharma and biotech industry. Prior to joining Enterprise, she was at GSK, and throughout her career, has worked in global roles leading clinical programs in Respiratory, Immunology and Rare diseases. She has led development teams and programs in several indications like Asthma, COPD, Cystic Fibrosis, Idiopathic Pulmonary Fibrosis, and Systemic Sclerosis, with successful approvals of products in many of these indications. Her previous roles have been with organisations such as Galapagos, Vertex, Takeda and Novartis.

Niyati received her degree in Medicine from India. She has also completed Diploma in Pharmaceutical Medicine from Universite Libre De Bruxelles (ULB), and Masters in Drug Development Science from Kings College, London.